摘要
目的探究咳嗽变异性哮喘使用沙美特罗/氟替卡松吸入治疗的效果。方法针对40例咳嗽变异性哮喘患者采用常规方法治疗,并归为对照组,针对另外40例咳嗽变异性哮喘患者使用沙美特罗/氟替卡松吸入治疗,并归为观察组,比较两组患者的治疗效果。结果两组患者在治疗前呼气流速峰值(PEF)、咳嗽评分无明显差异,经过分组治疗后观察组患者出现明显改善;观察组患者的恢复时间明显较快(P<0.05)。结论沙美特罗/氟替卡松吸入治疗咳嗽变异性哮喘效果较好。
Objective To investigate the effect of salmeterol / fluticasone （inhalation） on cough variant asthma. Methods 40 cases of patients with cough variant asthma were treated with conventional methods in the control group. 40 cases of patients were treated with salmeterol / fluticasone （inhalation） as observation group. The results were compared with peak flow rate （PEF） and cough score between the two groups. Results There was no significant difference in peak flow rate （PEF） and cough score between the two groups before treatment, and the patients in the observation group were significantly improved after the group therapy. The recovery time of the observation group was significantly faster. Conclusion Salmeterol / fluticasone （inhalation） treatment is to help patients with cough variant asthma to improve respiratory function, and patients recover in a timely manner.
出处
《中国处方药》
2017年第11期81-82,共2页
Journal of China Prescription Drug
